Montpellier, France — January 14th, 2021 — CILcare, the world-leading CRO specialized in the field of hearing, recently had the immense pleasure of welcoming Dr. Mathieu Schué to the team as Project Director of Drug Development & Translational Research. In this role, Mathieu Schué will dive into CILcare’s preclinical models and read-outs, validate reference compounds […]
Category Archives: News
Press Release: CBSET partner CILcare opens new subsidiary in Denmark
Montpellier, France — November 9, 2020 — CBSET partner CILcare, a world leading CRO entirely dedicated to ear disorders, announced today the opening of a new subsidiary in Copenhagen, Denmark. Already established in the US, the French company is joining the Medicon Valley Alliance, a leading international life-sciences cluster in Northern Europe. This second subsidiary […]
Endovascular Today: CBSET Preclinical Study Shows Balloon-Based Drug Delivery Is Critically Dependent on Coating Micromorphology
September 30, 2020—CBSET Inc., a not-for-profit translational research institute, announced the publication of a preclinical study, “Balloon-based drug coating delivery to the artery wall is dictated by coating micro-morphology and angioplasty pressure gradients,” by Abraham R. Tzafriri, PhD, et al, online ahead of print in the Journal of Biomaterials.
Press Release: Preclinical studies reveal balloon-based drug delivery to be critically dependent on coating micro-morphology, suggesting a paradigm for accelerated treatment optimization
“These preclinical studies transform our understanding of how drug coated balloons deliver drug to the artery and why there is no class effect, while also providing tools for understanding the role of tissue stiffening with disease. The combination of mechanistic insight with predictive modeling can help accelerate development of new technologies such as those including […]
Press Release: CILcare-CBSET nominated for the prestigious PRIX Galien Medstartup award in the ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide’ Category
LEXINGTON, MA — September 23, 2020 — CBSET Inc., a not-for-profit translational research institute, announced today that the company and its partner, CILcare, a leading CRO specializing in hearing disorders, have been nominated to receive a prestigious Prix Galien MedStartUp award for their collaboration in fighting hearing loss; the collaborators are nominated in the category […]
Medical Alley: COVID-19 and Quarantine – Can’t keep a medical device start-up down
COVID-19 has significantly and adversely affected preclinical research and clinical trials across the universe of life science companies as a result of the suspension of elective procedures in the U.S. and globally, as well as the challenges posed by travel bans, the furlough of or requirement that clinical study personnel work remotely, restrictions on access […]
Press Release: CILcare enhances its regulatory expertise with Marie-Pierre Pasdelou’s appointment as Chief Regulatory Officer
Montpellier, France, and Lexington, MA — September 3rd, 2020 — CILcare, world leading CRO specialized in the field of hearing, announced today that Dr. Marie-Pierre PASDELOU, CILcare’s co-founder and current Chief Development Officer, is taking over CILcare’s Regulatory Affairs and Quality Department as Chief Regulatory Officer. In parallel to offering CILcare’s sponsors strategic and operational […]
Press Release: CILcare extends its expertise to develop solutions for people with vestibular disorders with its partner Vertidiag
Montpellier, France, and Lexington, MA — June 15, 2020 — CILcare, world leading CRO entirely specialized in the field of hearing disorders, announces a strategic partnership with the start-up Vertidiag, a company specialized in balance disorders. By combining their unique know-how, CILcare and Vertidiag can propose a complete service offering to identify and develop therapeutic solutions […]
Press Release: CBSET Partner CILcare Promotes Dr. Cyrille Sage to Director of U.S. Operations
LEXINGTON, MA, May 19, 2020 — CBSET Inc., a not-for-profit translational research institute, announced today that its partner, CILcare, a leading CRO specializing in hearing disorders, has promoted Dr. Cyrille Sage to Director of CILcare’s U.S. operations. In his new role, Dr. Sage will be responsible for overseeing all operations performed at the joint CBSET-CILcare facility […]
Press Release: CBSET partner CILcare promotes Dr. Wahid Awad to Chief Business Officer and elects him to Board of Directors
LEXINGTON, MA, April 27, 2020 — CBSET Inc., a not-for-profit translational research institute, announced today that its partner, CILcare, a leading CRO specializing in hearing disorders, has promoted Dr. Wahid Awad to Chief Business Officer (CBO); and, the company further announced that Dr. Awad has been elected to its Board of Directors. Previously, Dr. Awad […]